232 related articles for article (PubMed ID: 31777082)
1. Impact of the pharmacist-led intervention on the control of medical cardiovascular risk factors for the primary prevention of cardiovascular disease in general practice: A systematic review and meta-analysis of randomised controlled trials.
Alshehri AA; Jalal Z; Cheema E; Haque MS; Jenkins D; Yahyouche A
Br J Clin Pharmacol; 2020 Jan; 86(1):29-38. PubMed ID: 31777082
[TBL] [Abstract][Full Text] [Related]
2. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Barnard S; Perel P; Free C
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
[TBL] [Abstract][Full Text] [Related]
5. Impact of Pharmacist-Led Interventions to Improve Clinical Outcomes for Adults With Type 2 Diabetes at Risk of Developing Cardiovascular Disease: A Systematic Review and Meta-analysis.
Alabkal RM; Medlinskiene K; Silcock J; Graham A
J Pharm Pract; 2023 Aug; 36(4):888-899. PubMed ID: 35579209
[TBL] [Abstract][Full Text] [Related]
6. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials.
Santschi V; Chiolero A; Burnand B; Colosimo AL; Paradis G
Arch Intern Med; 2011 Sep; 171(16):1441-53. PubMed ID: 21911628
[TBL] [Abstract][Full Text] [Related]
7. A systematic review investigating the role and impact of pharmacist interventions in cardiac rehabilitation.
Ahmed A; Guo P; Jalal Z
Int J Clin Pharm; 2023 Apr; 45(2):320-329. PubMed ID: 36401764
[TBL] [Abstract][Full Text] [Related]
8. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials.
Cheema E; Sutcliffe P; Singer DR
Br J Clin Pharmacol; 2014 Dec; 78(6):1238-47. PubMed ID: 24966032
[TBL] [Abstract][Full Text] [Related]
9. Pharmacist Interventions in the Management of Type 2 Diabetes Mellitus: A Systematic Review of Randomized Controlled Trials.
Pousinho S; Morgado M; Falcão A; Alves G
J Manag Care Spec Pharm; 2016 May; 22(5):493-515. PubMed ID: 27123912
[TBL] [Abstract][Full Text] [Related]
10. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.
Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011163. PubMed ID: 26272648
[TBL] [Abstract][Full Text] [Related]
11. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.
Weeks G; George J; Maclure K; Stewart D
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011227. PubMed ID: 27873322
[TBL] [Abstract][Full Text] [Related]
12. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis.
Tan EC; Stewart K; Elliott RA; George J
Res Social Adm Pharm; 2014; 10(4):608-22. PubMed ID: 24161491
[TBL] [Abstract][Full Text] [Related]
13. Community pharmacist-led interventions to improve medication adherence in patients with cardiovascular disease: a systematic review of randomised controlled trials.
Al-Arkee S; Al-Ani O
Int J Pharm Pract; 2023 May; 31(3):269-275. PubMed ID: 36821553
[TBL] [Abstract][Full Text] [Related]
14. Does Collaboration between General Practitioners and Pharmacists Improve Risk Factors for Cardiovascular Disease and Diabetes? A Systematic Review and Meta-Analysis.
Chaudhri K; Caleres G; Saunders S; Michail P; Di Tanna GL; Lung T; Liu H; Joshi R
Glob Heart; 2023; 18(1):7. PubMed ID: 36846722
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist services for non-hospitalised patients.
de Barra M; Scott CL; Scott NW; Johnston M; de Bruin M; Nkansah N; Bond CM; Matheson CI; Rackow P; Williams AJ; Watson MC
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD013102. PubMed ID: 30178872
[TBL] [Abstract][Full Text] [Related]
16. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries.
Pande S; Hiller JE; Nkansah N; Bero L
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD010398. PubMed ID: 23450614
[TBL] [Abstract][Full Text] [Related]
17. Pharmacist Interventions in the Management of Blood Pressure Control and Adherence to Antihypertensive Medications: A Systematic Review of Randomized Controlled Trials.
Reeves L; Robinson K; McClelland T; Adedoyin CA; Broeseker A; Adunlin G
J Pharm Pract; 2021 Jun; 34(3):480-492. PubMed ID: 32067555
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review and Meta-Analysis of Medication Reviews Conducted by Pharmacists on Cardiovascular Diseases Risk Factors in Ambulatory Care.
Martínez-Mardones F; Fernandez-Llimos F; Benrimoj SI; Ahumada-Canale A; Plaza-Plaza JC; S Tonin F; Garcia-Cardenas V
J Am Heart Assoc; 2019 Nov; 8(22):e013627. PubMed ID: 31711390
[TBL] [Abstract][Full Text] [Related]
19. Impact of community-pharmacist-led medication review programmes on patient outcomes: A systematic review and meta-analysis of randomised controlled trials.
Al-Babtain B; Cheema E; Hadi MA
Res Social Adm Pharm; 2022 Apr; 18(4):2559-2568. PubMed ID: 33965357
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
